KORYTINA, G.F.,
AKHMADISHINA, L.Z.,
KOCHETOVA, O.V.,
NASIBULLIN, T.R.,
AZNABAEVA, Y.G.,
ZULKARNEEV, S.R.,
IZMAǏLOVA, S.M.,
ZAGIDULLIN, S.Z.,
VICTOROVA, T.V. (2021) of the
respiratory system. Smoking is a major risk factor of COPD. Neurotransmitter system genes were
testedPashirova, T.N.,
Shaihutdinova, Z.M.,
Vandyukov, A.E.,
Lyubina, A.P.,
Amerhanova, S.K.,
Voloshina, A.D.,
Samorodov, A.V.,
Souto, E.B.,
Mironov, V.F.,
Mironov, V.F. (2022) -positive and gram-negative bacteria, fungi, hemolytic activity, cell toxicity (MTT-
test) and in vitro anticoagulant
Dobrodeeva, V.S.,
Shnayder, N.A.,
Novitsky, M.A.,
Asadullin, A.R.,
Vaiman, E.E.,
Petrova, M.M.,
Limankin, O.V.,
Neznanov, N.G.,
Garganeeva, N.P.,
Nasyrova, R.F. (2022) ). The mean duration of APs monotherapy was 8 weeks. The biochemical blood
test included levels of glucose
ЗАЩИТА ОТ ТРАВМАТИЗМА ЛЮДЕЙ С НАРУШЕНИЕМ РАВНОВЕСИЯ И КООРДИНАЦИИ ДВИЖЕНИЯGrigorieva, Z.R.,
Budeeva, O.N.,
Solodushenkova, T.S.,
Minasov, T.B.,
Blinova, N.M.,
ГРИГОРЬЕВА, З.Р.,
БУДЕЕВА, О.Н.,
СОЛОДУШЕНКОВА, Т.С.,
МИНАСОВ, Т.Б.,
БЛИНОВА, Н.М (2025) covered with a protective element have been carried out. Positive
test results have been obtained. Thus